New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases
One of the reasons cancer is so deadly is that it can evade attack from the body’s immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard’s School of Engineering and Applied Sciences (SEAS) show a non–surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.
“We can create 3D structures using minimally–invasive delivery to enrich and activate a host’s immune cells to target and attack harmful cells in vivo,” said the study’s senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty member and the Robert P. Pinkas Professor of Bioengineering at Harvard SEAS.
Tiny biodegradable rod–like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three–dimensional scaffold, like pouring a box of matchsticks into a pile on a table. The porous spaces in the stack of MSRs are large enough to recruit and fill up with dendritic cells, which are “surveillance” cells that monitor the body and trigger an immune response when a harmful presence is detected.
“Nano–sized mesoporous silica particles have already been established as useful for manipulating individual cells from the inside, but this is the first time that larger particles, in the micron–sized range, are used to create a 3D in vivo scaffold that can recruit and attract tens of millions of immune cells,” said co-lead author Jaeyun Kim, Ph.D., an Assistant Professor of Chemical Engineering at Sungkyunkwan University and a former Wyss Institute Postdoctoral Fellow.
Synthesized in the lab, the MSRs are built with small holes, known as nanopores, inside. The nanopores can be filled with specific cytokines, oligonucleotides, large protein antigens, or any variety of drugs of interest to allow a vast number of possible combinations to treat a range of infections.
“Although right now we are focusing on developing a cancer vaccine, in the future we could be able to manipulate which type of dendritic cells or other types of immune cells are recruited to the 3D scaffold by using different kinds of cytokines released from the MSRs,” said co-lead author Aileen Li, a graduate student pursuing her Ph.D. in bioengineering at Harvard SEAS. “By tuning the surface properties and pore size of the MSRs, and therefore controlling the introduction and release of various proteins and drugs, we can manipulate the immune system to treat multiple diseases.”
The Latest on: Injectable 3D vaccines
via Google News
The Latest on: Injectable 3D vaccines
- Coronavirus treatments: Everything you need to know about chloroquine and vaccineson March 23, 2020 at 4:34 pm
A number of treatments and vaccines have been proposed to tackle the COVID-19 pandemic. Here's what you need to know about them.
- Coronavirus vaccines, treatments and chloroquine: Everything you need to knowon March 19, 2020 at 4:09 pm
Vaccines to halt the spread of COVID-19 have been trialed in human patients for the first time, but experts suggest they are still a year away. COVID-19, the potentially fatal respiratory illness ...
- US begins first human trial of coronavirus vaccineon March 16, 2020 at 5:56 pm
The first human trial to evaluate a candidate vaccine against the new coronavirus has begun in Seattle ... The Seattle trial will study the impact of different doses delivered by intramuscular ...
- Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge studyon March 13, 2020 at 3:14 am
Influenza virus remains at the forefront of public health research due to the high morbidity and mortality associated with yearly epidemics and sporadic pandemics. Seasonal influenza is estimated to ...
- Hepatitis C Virus Vaccines in the Era of New Direct-acting Antiviralson March 10, 2020 at 5:00 pm
Integration of novel computational and structure-based design of vaccine candidates to improve epitope selection. These attempts probably require 3D structures of the viral particle and high ...
- University Entrepreneurship Week: 10 startups to watchon March 10, 2020 at 12:28 pm
When researchers in the United States worked to create the first 3D, atomic-scale map of the part of the novel coronavirus that infects human cells, a key step toward creating a vaccine, they relied ...
- Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabeteson March 9, 2020 at 3:12 am
Therapeutic approaches to combat type 1 diabetes (T1D) include donor pancreas transplantation, exogenous insulin administration and immunosuppressive therapies. However, these clinical applications ...
- An oral microjet vaccination system elicits antibody production in rabbitson March 5, 2020 at 4:00 pm
We show that the vaccine ... (3D) printer out of a photopolymerizable plastic resin, which is biocompatible and water-resistant (21, 22). The device is designed to be compatible with industry-scale ...
- Improving Medicine with Physicson February 26, 2020 at 4:00 pm
"One of our most recent innovations has been to develop 3D sponge-like electrodes that ... Laser Drug Delivery Needle-free injection is an emerging form of drug delivery that forcefully pushes ...
- U of T Entrepreneurship Week: 10 startups to watchon February 28, 2018 at 2:48 pm
With Entrepreneurship Week underway, here’s a look at 10 exciting U of T startups to keep an eye on in 2020: When researchers in the United States worked to create the first 3D, atomic-scale map of ...
via Bing News